SDIX's Q2 Revenues Rise 4 Percent | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Biotech firm SDIX posted a 4 percent hike year over year in revenues for the second quarter, with its Life Science business climbing 13 percent, it reported after the close of the market Thursday.

For the three months ended June 30, revenues increased to $7.1 million, compared to $6.8 million during the second quarter of 2010. Life Science sales rose to $4.2 million from $3.7 million in the year-ago period.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.